Small Business Investment Companies; Increase in Maximum Leverage Ceiling, 79536-79537 [Z8-29027]
Download as PDF
79536
Federal Register / Vol. 73, No. 249 / Monday, December 29, 2008 / Notices
consistent with the protection of
investors and the public interest.10
The Exchange has requested that the
Commission waive the 30-day operative
delay, so that the proposed rule change
may become operative upon filing. The
Commission hereby grants the
Exchange’s request and believes that
waiving the 30-day operative delay is
consistent with the protection of
investors and the public interest.11 As a
result of this action, the Exchange will
be able to implement without undue
delay a proposed rule change that
reduces the likelihood of quotations or
orders on NYSE Bonds from being
stepped ahead of by an insignificant
amount. Accordingly, the Commission
designates the proposed rule change
operative upon filing with the
Commission.
At any time within 60 days of the
filing of the proposed rule change, the
Commission may summarily abrogate
such rule change if it appears to the
Commission that such action is
necessary or appropriate in the public
interest, for the protection of investors,
or otherwise in furtherance of the
purposes of the Act.
IV. Solicitation of Comments
Interested persons are invited to
submit written data, views, and
arguments concerning the foregoing,
including whether the proposed rule
change is consistent with the Act.
Comments may be submitted by any of
the following methods:
Electronic Comments
• Use the Commission’s Internet
comment form (https://www.sec.gov/
rules/sro.shtml); or
• Send an e-mail to rulecomments@sec.gov. Please include File
Number SR–NYSE–2008–129 on the
subject line.
Paper Comments
• Send paper comments in triplicate
to Secretary, Securities and Exchange
Commission, 100 F Street, NE.,
Washington, DC 20549–1090.
All submissions should refer to File
Number SR–NYSE–2008–129. This file
number should be included on the
subject line if e-mail is used. To help the
dwashington3 on PROD1PC60 with NOTICES
10 In
addition, Rule 19b–4(f)(6)(iii) requires a selfregulatory organization to give the Commission
written notice of its intent to file the proposed rule
change at least five business days prior to the date
of filing of the proposed rule change, or such
shorter time as designated by the Commission. The
Commission has determined to waive the five-day
pre-filing notice requirement in this case.
11 For the purposes only of waiving the 30-day
operative delay, the Commission has considered the
proposed rule’s impact on efficiency, competition,
and capital formation. See 15 U.S.C. 78c(f).
VerDate Aug<31>2005
13:19 Dec 24, 2008
Jkt 217001
Commission process and review your
comments more efficiently, please use
only one method. The Commission will
post all comments on the Commission’s
Internet Web site (https://www.sec.gov/
rules/sro.shtml). Copies of the
submission, all subsequent
amendments, all written statements
with respect to the proposed rule
change that are filed with the
Commission, and all written
communications relating to the
proposed rule change between the
Commission and any person, other than
those that may be withheld from the
public in accordance with the
provisions of 5 U.S.C. 552, will be
available for inspection and copying in
the Commission’s Public Reference
Room, 100 F Street, NE., Washington,
DC 20549, on official business days
between the hours of 10 a.m. and 3 p.m.
Copies of the filing also will be available
for inspection and copying at the
principal office of the Exchange. All
comments received will be posted
without change; the Commission does
not edit personal identifying
information from submissions. You
should submit only information that
you wish to make available publicly. All
submissions should refer to File
Number SR–NYSE–2008–129 and
should be submitted on or before
January 20, 2009.
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.12
Florence E. Harmon,
Acting Secretary.
[FR Doc. E8–30789 Filed 12–24–08; 8:45 am]
BILLING CODE 8011–01–P
SMALL BUSINESS ADMINISTRATION
Administrator’s Line of Succession
Designation, No. 1–A, Revision 29
This document replaces and
supersedes ‘‘Line of Succession
Designation No. 1–A, Revision 28.’’
Line of Succession Designation No. 1–
A, Revision 29
Effective immediately, the
Administrator’s Line of Succession
Designation is as follows:
(a) In the event of my inability to
perform the functions and duties of my
position, or my absence from the office,
the Deputy Administrator will assume
all functions and duties of the
Administrator. In the event the Deputy
Administrator and I are both unable to
perform the functions and duties of the
position or are absent from our offices,
12 17
PO 00000
CFR 200.30–3(a)(12).
Frm 00100
Fmt 4703
Sfmt 4703
I designate the officials in listed order
below, if they are eligible to act as
Administrator under the provisions of
the Federal Vacancies Reform Act of
1998, to serve as Acting Administrator
with full authority to perform all acts
which the Administrator is authorized
to perform:
(1) Chief of Staff
(2) General Counsel
(3) Associate Administrator for
Management and Administration
(4) Chief Financial Officer
(5) Regional Administrator for Region 1
(b) Notwithstanding the provisions of
SBA Standard Operating Procedure 00
01 2, ‘‘absence from the office,’’ as used
in reference to myself in paragraph (a)
above, means the following:
(1) I am not present in the office and
cannot be reasonably contacted by
phone or other electronic means, and
there is an immediate business necessity
for the exercise of my authority; or
(2) I am not present in the office and,
upon being contacted by phone or other
electronic means, I determine that I
cannot exercise my authority effectively
without being physically present in the
office.
(c) An individual serving in an acting
capacity in any of the positions listed in
subparagraphs (a) (1) through (5), unless
designated as such by the
Administrator, is not also included in
this Line of Succession. Instead, the
next non-acting incumbent in the Line
of Succession shall serve as Acting
Administrator.
(d) This designation shall remain in
full force and effect until revoked or
superseded in writing by the
Administrator, or by the Deputy
Administrator when serving as Acting
Administrator.
(e) Serving as Acting Administrator
has no effect on the officials listed in
subparagraphs (a)(1) through (5), above,
with respect to their full-time position’s
authorities, duties and responsibilities
(except that such official cannot both
recommend and approve an action).
Dated: December 18, 2008.
Sandy K. Baruah,
Acting Administrator.
[FR Doc. E8–30774 Filed 12–24–08; 8:45 am]
BILLING CODE 8025–01–P
SMALL BUSINESS ADMINISTRATION
Small Business Investment
Companies; Increase in Maximum
Leverage Ceiling
Correction
In Notice document E8–29027
appearing on page 75488 in the issue of
Thursday, December 11, 2008, make the
following correction:
E:\FR\FM\29DEN1.SGM
29DEN1
79537
Federal Register / Vol. 73, No. 249 / Monday, December 29, 2008 / Notices
The table should appear as follows:
If your leverageable capital is:
Then your maximum leverage is:
(1)
(2)
(3)
(4)
300 percent of Leverageable Capital.
$68,400,000 + [2 x (Leverageable Capital ¥$22,800,000)].
$114,200,000 + (Leverageable Capital ¥$45,700,000).
$137,100,000.
Not over $22,800,000 .........................................................................
Over $22,800,000 but not over $45,700,000 .....................................
Over $45,700,000 but not over $68,600,000 .....................................
Over $68,600,000 ...............................................................................
[FR Doc. Z8–29027 Filed 12–24–08; 8:45 am]
BILLING CODE 1505–01–D
SOCIAL SECURITY ADMINISTRATION
Agency Information Collection
Activities: Comment Request
The Social Security Administration
(SSA) publishes a list of information
collection packages requiring clearance
by the Office of Management and
Budget (OMB) in compliance with
Public Law (Pub. L.) 104–13, the
Paperwork Reduction Act of 1995,
effective October 1, 1995. This notice
includes revisions to existing OMBapproved information collections.
SSA is soliciting comments on the
accuracy of the agency’s burden
estimate; the need for the information;
its practical utility; ways to enhance its
quality, utility, and clarity; and ways to
minimize the burden on respondents,
including the use of automated
collection techniques or other forms of
information technology. Mail, e-mail, or
fax your comments and
recommendations on the information
collection(s) to the OMB Desk Officer
and the SSA Reports Clearance Officer
to the addresses or fax numbers listed
below.
(OMB), Office of Management and
Budget, Attn: Desk Officer for SSA, Fax:
202–395–6974, E-mail address:
OIRA_Submission@omb.eop.gov.
(SSA), Social Security
Administration, DCBFM, Attn: Reports
Clearance Officer, 1332 Annex Building,
6401 Security Blvd., Baltimore, MD
21235, Fax: 410–965–6400, E-mail
address: OPLM.RCO@ssa.gov.
The information collections below are
pending at SSA. SSA will submit them
to OMB within 60 days from the date of
this notice. Therefore, your comments
would be most helpful if you submit
them to SSA within 60 days from the
date of this publication. Individuals can
obtain copies of these collection
instruments by calling the SSA Reports
Clearance Officer at 410–965–0454 or by
writing to the e-mail address listed
above.
1. Application for EXTRA Help with
Medicare Prescription Drug Plan
Number of
respondents
Form type
Costs—20 CFR 418.3101—0960–0696.
The Medicare Modernization Act of
2003 mandated the creation of the
Medicare Part D prescription drug
coverage program and provided for
certain subsidies for eligible Medicare
beneficiaries to help pay for the costs of
prescription drugs. SSA uses Form
SSA–1020 (and the i1020, its electronic
counterpart), the Application for Extra
Help with Medicare Prescription Drug
Plan Costs, to collect information to
make Part D subsidy eligibility
determinations.
In compliance with Public Law 110–
275, beginning in January 2010, SSA
will use a new version of Form SSA–
1020. In this new version, SSA will
eliminate questions about the value of
life insurance policies and in-kind
support and maintenance, and we will
ask applicants about their interest in
applying for the Medicare Savings
Program. This information collection
request (ICR) is for the new version we
will use in 2010. The respondents are
Medicare beneficiaries who are applying
for the Medicare Part D subsidy.
Frequency of
response
Average burden per
response
(minutes)
Estimated
annual burden
(hours)
SSA–1020 (paper application form) ................................................................
i1020 (online application) .................................................................................
Field office interview ........................................................................................
560,000
240,000
200,000
1
1
1
30
40
30
280,000
160,000
100,000
Totals ........................................................................................................
1,000,000
........................
........................
540,000
dwashington3 on PROD1PC60 with NOTICES
2. Medicare Subsidy Quality Review
Forms—20 CFR 418(b)(5)—0960–0707.
The Medicare Modernization Act of
2003 mandated the creation of the
Medicare Part D prescription drug
coverage program and provided for
certain subsidies for eligible Medicare
beneficiaries to help pay for the costs of
prescription drugs. As part of its
stewardship duties of the Medicare Part
D subsidy program, SSA must conduct
periodic quality review checks of the
information Medicare beneficiaries
report on their subsidy applications
(Form SSA–1020). SSA uses the
Medicare Quality Review program to
conduct these checks.
Beginning in January 2010, SSA will
revise the Medicare Quality Review
system to comply with Public Law 110–
275. Specifically, we will: (1) Eliminate
the use of Form SSA–9309, the Life
Number of
respondents
Form number and name
SSA–9301 (Medicare Subsidy Quality Review Case Analysis Questionnaire)
VerDate Aug<31>2005
13:19 Dec 24, 2008
Jkt 217001
PO 00000
Frm 00101
Fmt 4703
Sfmt 4703
Insurance Verification form; and (2)
remove any questions about life
insurance policy values and in-kind
support and maintenance from the other
forms in the collection. This ICR is for
the revised Medicare Quality Review
System, which we will not use until
January 2010. The respondents are
applicants for the Medicare Part D
subsidy whom we have chosen to
undergo a Quality Review.
Frequency of
response
5,000
E:\FR\FM\29DEN1.SGM
1
29DEN1
Average
burden per
response
(minutes)
30
Estimated
annual burden
(hours)
2,500
Agencies
[Federal Register Volume 73, Number 249 (Monday, December 29, 2008)]
[Notices]
[Pages 79536-79537]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: Z8-29027]
SMALL BUSINESS ADMINISTRATION
Small Business Investment Companies; Increase in Maximum Leverage
Ceiling
Correction
In Notice document E8-29027 appearing on page 75488 in the issue of
Thursday, December 11, 2008, make the following correction:
[[Page 79537]]
The table should appear as follows:
------------------------------------------------------------------------
If your leverageable capital is: Then your maximum leverage is:
------------------------------------------------------------------------
(1) Not over $22,800,000............... 300 percent of Leverageable
Capital.
(2) Over $22,800,000 but not over $68,400,000 + [2 x
$45,700,000. (Leverageable Capital -
$22,800,000)].
(3) Over $45,700,000 but not over $114,200,000 + (Leverageable
$68,600,000. Capital -$45,700,000).
(4) Over $68,600,000................... $137,100,000.
------------------------------------------------------------------------
[FR Doc. Z8-29027 Filed 12-24-08; 8:45 am]
BILLING CODE 1505-01-D